IONS IONIS PHARMACEUTICALS INC
Nasdaq · SEC CIK 874015 · EDGAR
- Bought, last 12 months
- $1.06M 1 purchases by 1 insiders
- Sold, last 12 months
- $155.27M 88 sales by 19 insiders
- Filings on record
- 492 since 2021-07-06, latest 2026-09-02 20:32
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Monia Brett P | CEO, Dir | — | $30.35M |
| HOUGEN ELIZABETH L | EVP, CFO, Fin | — | $21.12M |
| BENNETT C FRANK | EVP, CSO | — | $16.71M |
| Geary Richard S | EVP, Chief Development Off | — | $13.35M |
| O'NEIL PATRICK R. | GC, EVP CLO | — | $9.17M |
| Devers Shannon L. | EVP, Chief Human Resources Ofc | — | $8.66M |
| Swayze Eric | EVP Research | — | $7.51M |
| LOSCALZO JOSEPH | Dir | — | $7.09M |
| KLEIN JOSEPH III | Dir | — | $6.00M |
| WENDER JOSEPH H | Dir | — | $5.44M |
Transactions 537
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-09-03 | 2024-08-28+ | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $49.40 | -651 | 85.2K | -0.8% | -$32.2K |
| 2024-08-06 | 2024-08-05 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $48.00 | -2,430 | 85.5K | -3% | -$116.6K | |
| DM | 2024-07-17 | 2024-07-16 | IONS | Diaz Allene M. | Dir | S - Sale+OE | $49.49 | -1,637 | 16.5K | -9% | -$81.0K |
| D | 2024-07-17 | 2024-07-15 | IONS | Diaz Allene M. | Dir | M - OptEx | $0.00 | +4,677 | 17.4K | +37% | $0 |
| DI | 2024-07-17 | 2024-07-16 | IONS | KLEIN JOSEPH III | Dir | S - Sale+OE | $50.00 | -12.0K | 0 | -100% | -$600.0K |
| DI | 2024-07-17 | 2024-07-16 | IONS | KLEIN JOSEPH III | Dir | M - OptEx | $24.42 | +12.0K | 12.0K | New | +$293.0K |
| D | 2024-07-17 | 2024-07-15 | IONS | PARSHALL B LYNNE | Dir | M - OptEx | $0.00 | +4,677 | 87.3K | +6% | $0 |
| DI | 2024-07-17 | 2024-07-15 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $0.00 | +4,677 | 132.8K | +4% | $0 |
| D | 2024-07-17 | 2024-07-15 | IONS | LOSCALZO JOSEPH | Dir | M - OptEx | $0.00 | +4,677 | 45.8K | +11% | $0 |
| D | 2024-07-17 | 2024-07-15 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $0.00 | +4,677 | 151.9K | +3% | $0 |
| D | 2024-07-17 | 2024-07-15 | IONS | HERMAN JOAN E | Dir | M - OptEx | $0.00 | +4,677 | 42.0K | +13% | $0 |
| D | 2024-06-20 | 2024-06-17 | IONS | BERTHELSEN SPENCER R | Dir | M - OptEx | $35.53 | +16.0K | 163.3K | +11% | +$568.5K |
| D | 2024-06-20 | 2024-06-17 | IONS | BERTHELSEN SPENCER R | Dir | S - Sale+OE | $40.29 | -16.0K | 147.3K | -10% | -$644.6K |
| DI | 2024-05-13 | 2024-05-09 | IONS | WENDER JOSEPH H | Dir | M - OptEx | $35.53 | +16.0K | 128.1K | +14% | +$568.5K |
| MI | 2024-05-07 | 2024-05-03 | IONS | KLEIN JOSEPH III | Dir | S - Sale | $42.71 | -6,000 | 2,000 | -75% | -$256.3K |
| D | 2024-04-17 | 2024-04-15 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +10.8K | 23.6K | +85% | $0 |
| D | 2024-04-17 | 2024-04-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $41.60 | -4,006 | 19.6K | -17% | -$166.6K |
| D | 2024-04-17 | 2024-04-15 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | +1,875 | 47.1K | +4% | $0 |
| D | 2024-04-17 | 2024-04-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $41.66 | -905 | 46.2K | -2% | -$37.7K |
| 2024-03-04 | 2024-02-29 | IONS | Birchler Brian | VP Level 14 | J - Other | $34.43 | +604 | 45.2K | +1% | +$20.8K | |
| 2024-03-04 | 2024-02-29 | IONS | Swayze Eric | Off. Level 14 | J - Other | $34.43 | +605 | 34.9K | +2% | +$20.8K | |
| 2024-03-04 | 2024-02-29 | IONS | Geary Richard S | Off. Level 14 | J - Other | $34.43 | +604 | 87.9K | +0.7% | +$20.8K | |
| 2024-03-04 | 2024-02-29 | IONS | Monia Brett P | CEO Level 15, Dir | J - Other | $34.43 | +538 | 174.3K | +0.3% | +$18.5K | |
| 2024-03-04 | 2024-02-29 | IONS | BENNETT C FRANK | Off. Level 14 | J - Other | $34.43 | +383 | 79.5K | +0.5% | +$13.2K | |
| 2024-02-16 | 2024-02-16 | IONS | Monia Brett P | CEO, Dir | S - Sale | $44.49 | -387 | 173.8K | -0.2% | -$17.2K | |
| 2024-02-02 | 2024-02-01 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | A - Grant | $0.00 | +3,820 | 50.6K | +8% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $49.67 | -1,961 | 48.7K | -4% | -$97.4K | |
| 2024-02-02 | 2024-02-01 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | A - Grant | $0.00 | +4,140 | 38.0K | +12% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | S - Sale | $49.60 | -2,125 | 35.8K | -6% | -$105.4K | |
| 2024-02-02 | 2024-02-02 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale | $49.52 | -1,853 | 79.1K | -2% | -$91.8K | |
| 2024-02-02 | 2024-02-01 | IONS | BENNETT C FRANK | EVP, CSO | A - Grant | $0.00 | +3,609 | 80.9K | +5% | $0 | |
| 2024-02-02 | 2024-02-01 | IONS | Swayze Eric | EVP Research | A - Grant | $0.00 | +3,715 | 36.2K | +11% | $0 | |
| M | 2024-02-02 | 2024-01-31+ | IONS | Swayze Eric | EVP Research | S - Sale | $51.63 | -12.7K | 32.5K | -28% | -$654.7K |
| 2024-02-02 | 2024-02-01 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | A - Grant | $0.00 | +4,140 | 95.0K | +5% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale | $49.54 | -2,125 | 92.9K | -2% | -$105.3K | |
| 2024-02-02 | 2024-02-02 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale | $50.04 | -1,961 | 87.3K | -2% | -$98.1K | |
| 2024-02-02 | 2024-02-01 | IONS | Geary Richard S | EVP, Chief Development Off | A - Grant | $0.00 | +3,820 | 89.3K | +4% | $0 | |
| 2024-02-02 | 2024-02-01 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | A - Grant | $0.00 | +4,033 | 51.9K | +8% | $0 | |
| 2024-02-02 | 2024-02-02 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale | $49.59 | -2,071 | 49.8K | -4% | -$102.7K | |
| 2024-02-02 | 2024-02-02 | IONS | Monia Brett P | CEO, Dir | S - Sale | $49.37 | -23.5K | 174.1K | -12% | -$1.16M | |
| M | 2024-02-02 | 2024-02-01 | IONS | Monia Brett P | CEO, Dir | A - Grant | $0.00 | +45.8K | 177.2K | +35% | $0 |
| 2024-01-29 | 2024-01-25 | IONS | Monia Brett P | CEO, Dir | S - Sale | $51.75 | -2,285 | 151.9K | -1% | -$118.2K | |
| 2024-01-29 | 2024-01-25 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale | $51.75 | -6,450 | 46.8K | -12% | -$333.8K | |
| D | 2024-01-18 | 2024-01-16 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $0.00 | +68.1K | 186.2K | +58% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $50.42 | -32.1K | 154.1K | -17% | -$1.62M |
| D | 2024-01-18 | 2024-01-17 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $50.42 | -5,482 | 47.9K | -10% | -$276.4K |
| D | 2024-01-18 | 2024-01-16 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $0.00 | +15.2K | 53.3K | +40% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | S - Sale+OE | $50.42 | -5,564 | 33.8K | -14% | -$280.5K |
| D | 2024-01-18 | 2024-01-16 | IONS | Cadoret-Manier Onaiza | EVP, Chf GL Pdt Str, Oper Ofc | M - OptEx | $0.00 | +15.1K | 39.4K | +62% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $50.42 | -7,338 | 85.5K | -8% | -$370.0K |
| D | 2024-01-18 | 2024-01-16 | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $0.00 | +19.9K | 92.8K | +27% | $0 |
| D | 2024-01-18 | 2024-01-16 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $0.00 | +20.6K | 61.0K | +51% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $50.42 | -7,744 | 53.3K | -13% | -$390.5K |
| D | 2024-01-18 | 2024-01-16 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $0.00 | +18.3K | 84.1K | +28% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $50.42 | -6,745 | 77.3K | -8% | -$340.1K |
| DI | 2024-01-18 | 2024-01-16 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +21 | 94 | +29% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $50.42 | -6,296 | 43.3K | -13% | -$317.4K |
| D | 2024-01-18 | 2024-01-16 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +17.1K | 49.6K | +52% | $0 |
| DI | 2024-01-18 | 2024-01-17 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $50.42 | -9 | 85 | -10% | -$453.78 |
| D | 2024-01-18 | 2024-01-17 | IONS | Birchler Brian | EVP, Corp, Development Ops | S - Sale+OE | $50.42 | -4,497 | 44.6K | -9% | -$226.7K |
| D | 2024-01-18 | 2024-01-16 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $0.00 | +12.1K | 49.1K | +33% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | S - Sale+OE | $50.42 | -8,683 | 90.9K | -9% | -$437.8K |
| D | 2024-01-18 | 2024-01-16 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $0.00 | +22.5K | 99.6K | +29% | $0 |
| D | 2024-01-18 | 2024-01-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +3,688 | 14.3K | +35% | $0 |
| D | 2024-01-18 | 2024-01-17 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $50.42 | -1,460 | 12.8K | -10% | -$73.6K |
| DI | 2024-01-18 | 2024-01-16 | IONS | Baroldi Joseph | EVP, Chief Business Off | M - OptEx | $0.00 | +1,353 | 2,204 | +159% | $0 |
| DI | 2024-01-18 | 2024-01-17 | IONS | Baroldi Joseph | EVP, Chief Business Off | S - Sale+OE | $50.42 | -564 | 1,640 | -26% | -$28.4K |
| D | 2024-01-17 | 2024-01-12 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $32.60 | +8,000 | 46.2K | +21% | +$260.8K |
| D | 2024-01-17 | 2024-01-12 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $53.50 | -8,000 | 38.2K | -17% | -$428.0K |
| D | 2024-01-02 | 2023-12-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | M - OptEx | $47.34 | +11.5K | 48.0K | +31% | +$544.4K |
| D | 2024-01-02 | 2023-12-28 | IONS | Birchler Brian | EVP, Corp, Development Ops | F - Tax | $50.50 | -11.0K | 37.0K | -23% | -$557.0K |
| D | 2024-01-02 | 2023-12-28 | IONS | Swayze Eric | EVP Research | M - OptEx | $47.34 | +27.1K | 59.6K | +83% | +$1.28M |
| D | 2024-01-02 | 2023-12-28 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $50.19 | -27.1K | 32.5K | -45% | -$1.36M |
| D | 2024-01-02 | 2023-12-28 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | F - Tax | $50.50 | -43.8K | 77.1K | -36% | -$2.21M |
| D | 2024-01-02 | 2023-12-28 | IONS | HOUGEN ELIZABETH L | EVP, CFO, Fin | M - OptEx | $47.34 | +45.2K | 120.9K | +60% | +$2.14M |
| D | 2023-12-28 | 2023-12-26 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | M - OptEx | $47.34 | +25.0K | 61.1K | +69% | +$1.18M |
| D | 2023-12-28 | 2023-12-26 | IONS | Schneider Eugene | EVP, Chf Clinical Develop Ofcr | S - Sale+OE | $51.46 | -25.0K | 36.1K | -41% | -$1.29M |
| DM | 2023-12-28 | 2023-12-26+ | IONS | PARSHALL B LYNNE | Dir | S - Sale+OE | $50.48 | -117.6K | 82.6K | -59% | -$5.94M |
| DM | 2023-12-28 | 2023-12-26+ | IONS | PARSHALL B LYNNE | Dir | M - OptEx | $47.34 | +117.6K | 125.1K | +1,574% | +$5.57M |
| D | 2023-12-28 | 2023-12-26 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | S - Sale+OE | $51.46 | -20.8K | 40.4K | -34% | -$1.07M |
| D | 2023-12-28 | 2023-12-26 | IONS | O'NEIL PATRICK R. | GC, EVP CLO | M - OptEx | $47.34 | +20.8K | 61.2K | +52% | +$985.9K |
| DM | 2023-12-22 | 2023-12-20+ | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $49.50 | -10.6K | 73.0K | -13% | -$525.3K |
| DM | 2023-12-22 | 2023-12-20+ | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $47.34 | +10.6K | 77.1K | +16% | +$502.4K |
| DM | 2023-12-22 | 2023-12-20+ | IONS | Monia Brett P | CEO, Dir | M - OptEx | $47.34 | +24.0K | 135.6K | +22% | +$1.14M |
| DM | 2023-12-22 | 2023-12-20+ | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $49.38 | -24.0K | 118.1K | -17% | -$1.19M |
| DM | 2023-12-22 | 2023-12-20+ | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $49.39 | -22.6K | 65.8K | -26% | -$1.12M |
| DM | 2023-12-22 | 2023-12-20+ | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $47.34 | +22.6K | 81.9K | +38% | +$1.07M |
| DM | 2023-12-18 | 2023-12-14 | IONS | BENNETT C FRANK | EVP, CSO | M - OptEx | $47.34 | +22.6K | 79.8K | +40% | +$1.07M |
| DM | 2023-12-18 | 2023-12-14 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale+OE | $49.58 | -22.6K | 65.8K | -26% | -$1.12M |
| DM | 2023-12-18 | 2023-12-14 | IONS | Geary Richard S | EVP, Chief Development Off | M - OptEx | $47.34 | +10.6K | 77.0K | +16% | +$502.4K |
| DM | 2023-12-18 | 2023-12-14 | IONS | Geary Richard S | EVP, Chief Development Off | S - Sale+OE | $49.58 | -10.6K | 73.0K | -13% | -$526.2K |
| DM | 2023-12-18 | 2023-12-14 | IONS | Monia Brett P | CEO, Dir | S - Sale+OE | $49.58 | -24.0K | 118.1K | -17% | -$1.19M |
| DM | 2023-12-18 | 2023-12-14 | IONS | Monia Brett P | CEO, Dir | M - OptEx | $47.34 | +24.0K | 133.0K | +22% | +$1.14M |
| 2023-11-17 | 2023-11-15 | IONS | KLEIN JOSEPH III | Dir | S - Sale | $50.00 | -2,000 | 16.3K | -11% | -$100.0K | |
| DI | 2023-10-18 | 2023-10-17 | IONS | Swayze Eric | EVP Research | S - Sale+OE | $47.95 | -52 | 73 | -42% | -$2,493 |
| DI | 2023-10-18 | 2023-10-16 | IONS | Swayze Eric | EVP Research | M - OptEx | $0.00 | +125 | 125 | New | $0 |
| 2023-10-16 | 2023-10-12 | IONS | Monia Brett P | CEO, Dir | S - Sale | $46.00 | -3,770 | 118.1K | -3% | -$173.4K | |
| 2023-09-29 | 2023-09-28 | IONS | BENNETT C FRANK | EVP, CSO | S - Sale | $46.50 | -4,460 | 65.8K | -6% | -$207.4K | |
| 2023-09-28 | 2023-09-26 | IONS | KLEIN JOSEPH III | Dir | S - Sale | $45.13 | -2,000 | 18.3K | -10% | -$90.3K | |
| 2023-09-28 | 2023-09-26 | IONS | PARSHALL B LYNNE | Dir | S - Sale | $45.13 | -10.0K | 82.6K | -11% | -$451.3K |
Purchase Sale Sale after option exercise All abbreviations